ARMISTICE MASTER FUND LTV
ARMISTICE MASTER FUND LTV
Status:
Active
Similar Organizations
American Beta corporation
American Beta corporation investment firm
Intensive Softshare
Intensive Softshare investment firm.
SAT Capital
A investment firm.
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-09-30 | Aterian | Armistice Master Fund LTV investment in Post-IPO Equity - Aterian | 20 M USD |
| 2022-07-22 | Addex Therapeutics | Armistice Master Fund LTV investment in Post-IPO Equity - Addex Therapeutics | 4.2 M USD |
More informations about "Armistice Master Fund LTV"
Armistice Master Fund LTV - Investments, Portfolio & Company Exits
Armistice Master Fund LTV investment firm. Start Free Trial . Chrome ExtensionSee details»
Addex Raises $4.2 million in Equity Financing
Geneva, Switzerland, July 22, 2022 – Addex Therapeutics Ltd (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery …See details»
Addex Therapeutics - Funding, Financials, Valuation & Investors
Organization. Addex Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Funding Rounds 20. ... Indivior …See details»
Addex Raises $4.2 million in Equity Financing - Yahoo Finance
Jul 22, 2022 Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, July 22, 2022 – Addex Therapeutics Ltd (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical …See details»
Armistice Master Fund LTV — 2 Investments, 2 Exits, 2 Portfolio ...
Armistice Master Fund LTV. Search. Overview Investments Unlock datapoints. Portfolio analytics Team News & Media. Add fund to favorites. Save this fund for later to form your own custom …See details»
Addex raised $4.2 million in equity funding - startupticker.ch
Jul 22, 2022 Now the company has gained some leeway. Addex entered into a definitive agreement with Armistice Master Fund LTV, a healthcare-focused institutional investor, to sell …See details»
Addex Raises $4.2 million in Equity Financing - Story Telling Co
Jul 22, 2022 Ad Hoc Announcement Pursuant to Art. 53 LR Geneva, Switzerland, July 22, 2022 – Addex Therapeutics Ltd (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical …See details»
Armistice Master Fund LTV - Crunchbase
Armistice Master Fund LTV investment firm. Search Crunchbase. Start Free TrialSee details»
Addex stock falls 11% amid $4.2M equity financing with Armistice
Jul 22, 2022 Addex Therapeutics (ADXN) said it was raising $4.2M via an equity agreement with Armistice Master Fund LTV.The Swiss company will sell 3.3M shares in the form of 550K …See details»
Armistice Capital Master Fund Ltd. | AUM 13F
Track the AUM, funds, and holdings for Armistice Capital Master Fund Ltd. over time. View the latest funds and 13F holdings. Compare against similar firms.See details»
ARMISTICE CAPITAL, LLC SC 13D/A Filing Concerning TTPH on …
Jul 28, 2020 (a), (f) The persons filing this statement are: (i) Armistice Capital, LLC, a Delaware limited liability company (“Armistice Capital”); (ii) Armistice Capital Master Fund Ltd., a …See details»
Armistice Master Fund LTV - Updates, News, Events, Signals
Edit Recent News & Activity Section. Funding Round • Sep 30, 2022. Aterian raised $20,000,000 / Post Ipo Equity from Armistice Master Fund LTVSee details»
Addex Raises $4.2 million in Equity Financing - BioSpace
Jul 22, 2022 Addex Therapeutics Ltd announced that it has entered into a definitive agreement with Armistice Master Fund LTV, a healthcare-focused institutional investor, to sell 3,300,000 …See details»
ARMISTICE CAPITAL, LLC Top 13F Holdings - WhaleWisdom.com
Armistice Capital is a hedge fund with 3 clients and discretionary assets under management (AUM) of $5,911,150,000 (Form ADV from 2024-05-31). Their last reported 13F filing for Q3 …See details»
Armistice Capital Portfolio | Steven Boyd 13F Holdings & Trades
Heatmaps of the top 13f holdings and a list of the largest trades made by Armistice Capital, the hedge fund managed by Steven Boyd. ... Armistice Capital: Steven Boyd: 11.73%: …See details»
Addex Completes $4.2 Million Equity Financing
Geneva, Switzerland, July 26, 2022 – Addex Therapeutics Ltd (SIX: ADXN and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery …See details»
Armistice Capital - Company Database - Wall Street Oasis
Steven Boyd, Chief Investment Officer, founded Armistice Capital in 2012. Steven was the first analyst at Senator Investment Group in 2008, joining the firm with its founders from York …See details»
Aterian - Funding, Financials, Valuation & Investors - Crunchbase
Armistice Master Fund LTV and MidCap Financial are the most recent investors. Aterian has invested in 4th & Heart on Mar 7, 2024. This investment ... How much funding has this …See details»
Post-IPO Equity - Aterian - 2022-09-30 - Crunchbase
Sep 30, 2022 Organization Name . Aterian . Announced Date Sep 30, 2022; Funding Type Post-IPO Equity; Money Raised . obfuscated. obfuscated. Lead Investors. Edit Lead Investors …See details»